Dynamic Effects of the Third Generation Bisphosphonate of Risedronate on Rat Osteoporotic Fractures for Clinical Usage Guidance
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dynamic Effects of the Third Generation Bisphosphonate of Risedronate on Rat Osteoporotic Fractures for Clinical Usage Guidance
Authors
Keywords
-
Journal
Orthopaedic Surgery
Volume 13, Issue 8, Pages 2433-2441
Publisher
Wiley
Online
2021-10-22
DOI
10.1111/os.13158
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Calcitonin and Bone Physiology: In Vitro, In Vivo, and Clinical Investigations
- (2020) Jingbo Xie et al. International Journal of Endocrinology
- Effects of bisphosphonates on osteoporosis: Focus on zoledronate
- (2020) Ahmad Oryan et al. LIFE SCIENCES
- Experimental and finite element analyses of bone strains in the growing rat tibia induced by in vivo axial compression
- (2019) Tanvir Mustafy et al. Journal of the Mechanical Behavior of Biomedical Materials
- Atypical femoral fracture in patients with bone metastasis receiving denosumab therapy: a retrospective study and systematic review
- (2019) Momoko Takahashi et al. BMC CANCER
- Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study
- (2019) Michael R McClung et al. Lancet Diabetes & Endocrinology
- Accumulation of microdamage at complete and incomplete fracture sites in a patient with bilateral atypical femoral fractures on glucocorticoid and bisphosphonate therapy
- (2018) Ken Iwata et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Combination therapy with low-dose teriparatide and zoledronate contributes to fracture healing on rat femoral fracture model
- (2018) Yuta Tsubouchi et al. Journal of Orthopaedic Surgery and Research
- A brief history of FRAX
- (2018) John A. Kanis et al. Archives of Osteoporosis
- The effect of long-term bisphosphonate therapy on trabecular bone strength and microcrack density
- (2017) A. Jin et al. Bone & Joint Research
- Bone Structure and Turnover Status in Postmenopausal Women with Atypical Femur Fracture After Prolonged Bisphosphonate Therapy
- (2016) Shijing Qiu et al. CALCIFIED TISSUE INTERNATIONAL
- Bisphosphonate-associated atypical sub-trochanteric femur fractures: Paired bone biopsy quantitative histomorphometry before and after teriparatide administration
- (2015) Paul D. Miller et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Fracture Prediction After Discontinuation of 4 to 5 Years of Alendronate Therapy
- (2014) Douglas C. Bauer et al. JAMA Internal Medicine
- Bisphosphonate-osteoclasts: Changes in osteoclast morphology and function induced by antiresorptive nitrogen-containing bisphosphonate treatment in osteoporosis patients
- (2013) Björn Jobke et al. BONE
- The relationship between osteoarthritis and osteoporosis
- (2013) Gun-Il Im et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Bisphosphonate Use and the Risk of Subtrochanteric or Femoral Shaft Fractures in Older Women
- (2011) Laura Y. Park-Wyllie JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Atypical fractures of the femur and bisphosphonate therapy
- (2010) Andrea Giusti et al. BONE
- Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: What we think we know and what we know that we don't know
- (2010) Matthew R. Allen et al. BONE
- The influence of compression on the healing of experimental tibial fractures
- (2010) Ulf Sigurdsen et al. INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
- Trends in Incidence of Subtrochanteric Fragility Fractures and Bisphosphonate Use Among the US Elderly, 1996-2007
- (2010) Zhong Wang et al. JOURNAL OF BONE AND MINERAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More